Accessibility Menu

Cordyceps Sunshine Biotech(OTC) RAJAF

Market Cap$577.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2024)+12,900%
5 YearN/A
1 Year-37%
1 Month+0%
$5.20
+72.76%
+2.19Today
Cordyceps Sunshine Biotech last closing stock price
MetricPriceDate
Last closeUSD 5.202025-12-31
Cordyceps Sunshine Biotech stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 5.202025-11-07
1 month+0%USD 5.202025-11-07
3 month-43.36%USD 9.182025-07-09
Year to date-36.97%USD 8.252024-12-23
1 year-36.97%USD 8.252024-12-23
Since inception+12,900%USD 0.042024-07-19

Cordyceps Sunshine Biotech Financials at a Glance

Market Cap

$577.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$5.20

Volume

1

Open

$5.20

Previous Close

$5.20

Daily Range

$4.85 - $5.20

52-Week Range

$3.01 - $9.18

Estimated Earnings Date

N/A

RAJAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cordyceps Sunshine Biotech

Cordyceps Sunshine Biotech Holdings Co., Ltd. specializes in the cultivating and sale of cordyceps. It engages in the research, development, manufacturing, and marketing of cordyceps, through its wholly-owned subsidiary, Chengdu Skyherb Biotechnology Co., Ltd. The company was founded on May 4, 2020 and is headquartered in Taipei, Taiwan.

Industry

Personal Products

Sector

Consumer Staples

Employees

16

CEO

Szu Hao Huang

Website

cordyceps-sunshine.com

RAJAF Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$577.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

111.12M

Volume

1

Avg. Volume

0

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Cordyceps Sunshine Biotech Performance Analysis

Cordyceps Sunshine Biotech annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 53,304-93.9%
20232023-12-31USD 882,5331555.7%
20242024-12-31USD 1,253,48442.0%
20252025-12-31USD 1,245,348-0.6%
Cordyceps Sunshine Biotech annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.0156.8%
20232023-12-31USD -0.00-85.5%
20242024-12-31USD -0.00100.0%
20252025-12-31USD -0.00-30.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$577.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About RAJAF

What is the current price of Cordyceps Sunshine Biotech?

Cordyceps Sunshine Biotech is trading at $5.20 per share.

What is the 52-week range for Cordyceps Sunshine Biotech?

Over the past 52 weeks, Cordyceps Sunshine Biotech has traded between $3.01 and $9.18.

How much debt does Cordyceps Sunshine Biotech have?

As of the most recent reporting period, Cordyceps Sunshine Biotech reported total debt of $718.52K.

How much cash does Cordyceps Sunshine Biotech have on hand?

Cordyceps Sunshine Biotech reported $3.20K in cash and cash equivalents in its most recent financial results.

What is Cordyceps Sunshine Biotech’s dividend yield?

Cordyceps Sunshine Biotech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services